A Brief Overview of VenaSeal: The New FDA-Approved Adhesive-Based Treatment for Varicose Veins
As mentioning in a previous piece, the United States regulatory agency responsible for approving new drugs and medical treatment for specific conditions, the United States Food and Drug Administration, has added one more tool to the vast array of treatment options to help those who suffer from varicose veins. Now, varicose veins are not generally associated with any major health crises, as they affect the superficial veins that run through the outer layers of the skin. Therefore, most treatments associated with getting rid of this unsightly problem for most people will fall as an elective cosmetic procedure for the purposes of insurance coverage. This means that the new system will probably be quite pricy in the beginning years of its existence, save for very severe cases of varicose veins that can actually be deemed a medical necessity. This will obviously vary to vary depending on the specific plan that the patient holds. However, due to recent healthcare reform in the United States, at least people who suffer from these conditions will no longer be subject to pre-existing condition denial of service, so the only barrier in receiving insurance approval will be to show why the treatment is medically necessary for the patient.
Moving forward, this new system for treating varicosity is called VenaSeal, and is a radically new approach to treating these ugly occurrences. Most previously-existing treatment consisted of either conservative treatment with compression stockings or surgical options that employ laser, radio wave, or traditional removal techniques for dealing with the problem. VenaSeal is actually an adhesive based approach that essentially “glues” the small veins shut, leading to their destruction and subsequent resolution. The main issue that patients will have to be concerned with is making sure that they do not have any known allergy to the material used to perform the procedure. It will overall still be somewhat of an invasive procedure, as the adhesive must be placed in the veins, but it is much less invasive than cutting the veins out in a traditional surgical approach. The important thing here is that, because the approach is radically new, there is a good chance that patient’s who have failed treatment with any of the current existing conservative measures or surgical measures may find some sort of benefit or may become an excellent candidate for this new treatment.
So, adding VenaSeal to the arsenal as a new treatment to get rid of varicose veins will greatly broaden the options available to hard-to-treat cases, and may even become a more attractive, less invasive treatment as some time passes and the treatment becomes more commonplace in American medicine. Either way you look at it, though, this is an exciting time for medical professionals that work with this condition as well as for the patients that they treat who may have lost hope due to failing some of the older treatments.